XTANT Medical Holdings, Inc. Files Form 8-K: Key Information for Investors

Date of Report: March 2, 2026
Company: XTANT Medical Holdings, Inc.
Exchange: NYSE American LLC
Trading Symbol: XTNT
SEC File Number: 001-34951
Central Index Key (CIK): 0001453593
State of Incorporation: Delaware (DE)
Type of Security Registered: Common stock, par value \$0.000001 per share

Key Points in the Report

• XTANT Medical Holdings, Inc. has filed a Form 8-K with the SEC, representing a current report under Sections 13 or 15(d) of the Securities Exchange Act of 1934. This is a standard regulatory filing for significant corporate events.
• No amendments were made to any previously filed or accepted submissions (Amendment Flag: false).
• The filing confirms the company’s security registration:
  • Common stock, par value \$0.000001 per share
  • Trading Symbol: XTNT
  • Registered on NYSE American LLC
• The company indicated false for all the following (i.e., not applicable):
  • Written communications under Rule 425
  • Solicitation of material under Rule 14a-12
  • Pre-commencement tender offers under Rule 14d-2(b)
  • Pre-commencement issuer tender offers under Rule 13e-4(c)
• Emerging Growth Company Status: XTANT Medical Holdings is not classified as an emerging growth company. They have not elected to use the extended transition period for new financial accounting standards.
• Former Legal or Registered Name: Not applicable; no change reported.

Important Information for Shareholders

• No material corporate events disclosed in this filing. The Form 8-K is a routine submission, confirming details about stock registration and compliance, with no amendments or price-sensitive disclosures.
• No change in company name, address, or other registration details.
• No new securities offerings, tender offers, mergers, acquisitions, or changes in executive leadership were announced.
• No bankruptcy proceedings or shell company status indicated.
• No accounting changes or material events that would impact financial results or market valuation.

Potential Price Sensitivity

Investor Takeaway: There are no disclosures in this Form 8-K that are likely to affect XTNT’s share price. The filing is a standard compliance update, with no indication of material events, financial changes, or corporate actions. Shareholders should be aware that this filing does not signal any new developments or risks.

Signature

The report was signed on behalf of XTANT Medical Holdings, Inc. by:
Sean E. Browne

Disclaimer

This article is provided for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. The information presented is based solely on the contents of XTANT Medical Holdings, Inc. Form 8-K filed on March 2, 2026, and no material events or price-sensitive disclosures were identified in this filing.

View Xtant Medical Holdings, Inc. Historical chart here